ZVRA שווי כולל של נכסי החברה Zevra Therapeutics Inc

Zevra Therapeutics (ZVRA) invests in energy-efficient transportation and hazardous waste processing in compliance with ESG principles. The business model relies on third-party contractors for drug synthesis and packaging, retaining only development and promotion. This chart of total assets, which stands at 279.58, confirms growth driven by active sales of the Niemann-Pick disease treatment and the development of a promising product portfolio.

Total assets represent the aggregate value of all resources and ownership rights that form the material basis of the business. This metric is calculated inversely via return on assets (ROA), making it sensitive to operational efficiency. By analyzing the company's total resources, an investor can track the dynamics of capital accumulation. The Zevra Therapeutics (ZVRA) strategy of outsourcing production and trials minimizes the ownership of physical assets, thereby optimizing the structure of this balance sheet indicator.